Ajanta Pharma Q4 net profit jumps 66% to Rs 202.72 cr, approves buyback of shares
The Mumbai-based pharma majors revenue came in at Rs 1,054.08 crore, up 20 percent from Rs 881.84 crore a year back.
Ajanta Pharma Equity Shares Of The Company Equity Shares Rupees Two Thousand Seven Hundred Seventy Rupees
Source: moneycontrol.com